1. Home
  2. ONDS vs ICUI Comparison

ONDS vs ICUI Comparison

Compare ONDS & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ondas Holdings Inc.

ONDS

Ondas Holdings Inc.

SELL

Current Price

$10.86

Market Cap

4.8B

ML Signal

SELL

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$129.92

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONDS
ICUI
Founded
2014
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
3.9B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
ONDS
ICUI
Price
$10.86
$129.92
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$19.00
$182.25
AVG Volume (30 Days)
79.2M
239.3K
Earning Date
03-25-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
30.68
100.62
EPS
N/A
0.03
Revenue
$7,192,694.00
$2,231,262,000.00
Revenue This Year
$583.96
N/A
Revenue Next Year
$267.70
$4.46
P/E Ratio
N/A
$4,183.33
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$107.02
52 Week High
$15.28
$160.29

Technical Indicators

Market Signals
Indicator
ONDS
ICUI
Relative Strength Index (RSI) 53.50 40.13
Support Level $8.77 $121.49
Resistance Level $11.90 $136.39
Average True Range (ATR) 0.95 5.30
MACD 0.07 -0.51
Stochastic Oscillator 66.21 28.59

Price Performance

Historical Comparison
ONDS
ICUI

About ONDS Ondas Holdings Inc.

Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: